nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP3A4—prostate cancer	0.193	1	CbGaD
Metronidazole—CYP2C8—Nilutamide—prostate cancer	0.0533	0.104	CbGbCtD
Metronidazole—CYP2C8—Abiraterone—prostate cancer	0.0442	0.0859	CbGbCtD
Metronidazole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0412	0.08	CbGbCtD
Metronidazole—CYP2C9—Bicalutamide—prostate cancer	0.0372	0.0723	CbGbCtD
Metronidazole—CYP2C9—Nilutamide—prostate cancer	0.0372	0.0723	CbGbCtD
Metronidazole—CYP2C8—Cabazitaxel—prostate cancer	0.0327	0.0635	CbGbCtD
Metronidazole—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0285	0.0554	CbGbCtD
Metronidazole—CYP2C9—Estrone—prostate cancer	0.0223	0.0433	CbGbCtD
Metronidazole—CYP3A4—Bicalutamide—prostate cancer	0.0216	0.042	CbGbCtD
Metronidazole—CYP3A4—Estramustine—prostate cancer	0.0201	0.0391	CbGbCtD
Metronidazole—CYP2C8—Estradiol—prostate cancer	0.0184	0.0357	CbGbCtD
Metronidazole—CYP3A4—Flutamide—prostate cancer	0.0179	0.0348	CbGbCtD
Metronidazole—CYP3A4—Abiraterone—prostate cancer	0.0179	0.0348	CbGbCtD
Metronidazole—CYP2C9—Capecitabine—prostate cancer	0.0169	0.0328	CbGbCtD
Metronidazole—CYP3A4—Cabazitaxel—prostate cancer	0.0133	0.0258	CbGbCtD
Metronidazole—CYP3A4—Estrone—prostate cancer	0.013	0.0252	CbGbCtD
Metronidazole—CYP2C9—Estradiol—prostate cancer	0.0128	0.0249	CbGbCtD
Metronidazole—CYP2C8—Etoposide—prostate cancer	0.012	0.0233	CbGbCtD
Metronidazole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0116	0.0225	CbGbCtD
Metronidazole—CYP3A4—Conjugated Estrogens—prostate cancer	0.00848	0.0165	CbGbCtD
Metronidazole—CYP3A4—Mitoxantrone—prostate cancer	0.00771	0.015	CbGbCtD
Metronidazole—CYP3A4—Estradiol—prostate cancer	0.00744	0.0145	CbGbCtD
Metronidazole—CYP3A4—Prednisone—prostate cancer	0.0064	0.0124	CbGbCtD
Metronidazole—CYP3A4—Etoposide—prostate cancer	0.00486	0.00945	CbGbCtD
Metronidazole—CYP3A4—Docetaxel—prostate cancer	0.00445	0.00864	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—prostate cancer	0.00332	0.00644	CbGbCtD
Metronidazole—Tinidazole—CYP3A4—prostate cancer	0.00222	1	CrCbGaD
Metronidazole—Rhinitis—Epirubicin—prostate cancer	3.53e-05	0.000164	CcSEcCtD
Metronidazole—Abdominal pain—Etoposide—prostate cancer	3.53e-05	0.000164	CcSEcCtD
Metronidazole—Body temperature increased—Etoposide—prostate cancer	3.53e-05	0.000164	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—prostate cancer	3.53e-05	0.000164	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—prostate cancer	3.53e-05	0.000164	CcSEcCtD
Metronidazole—Nervous system disorder—Capecitabine—prostate cancer	3.52e-05	0.000164	CcSEcCtD
Metronidazole—Vertigo—Prednisone—prostate cancer	3.52e-05	0.000164	CcSEcCtD
Metronidazole—Hepatitis—Epirubicin—prostate cancer	3.52e-05	0.000164	CcSEcCtD
Metronidazole—Thrombocytopenia—Capecitabine—prostate cancer	3.52e-05	0.000163	CcSEcCtD
Metronidazole—Syncope—Prednisone—prostate cancer	3.52e-05	0.000163	CcSEcCtD
Metronidazole—Hypoaesthesia—Epirubicin—prostate cancer	3.5e-05	0.000163	CcSEcCtD
Metronidazole—Pharyngitis—Epirubicin—prostate cancer	3.5e-05	0.000162	CcSEcCtD
Metronidazole—Skin disorder—Capecitabine—prostate cancer	3.49e-05	0.000162	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—prostate cancer	3.48e-05	0.000162	CcSEcCtD
Metronidazole—Hyperhidrosis—Capecitabine—prostate cancer	3.47e-05	0.000161	CcSEcCtD
Metronidazole—Connective tissue disorder—Epirubicin—prostate cancer	3.46e-05	0.000161	CcSEcCtD
Metronidazole—Loss of consciousness—Prednisone—prostate cancer	3.45e-05	0.00016	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—prostate cancer	3.43e-05	0.00016	CcSEcCtD
Metronidazole—Anorexia—Capecitabine—prostate cancer	3.42e-05	0.000159	CcSEcCtD
Metronidazole—Nausea—Estradiol—prostate cancer	3.42e-05	0.000159	CcSEcCtD
Metronidazole—Vomiting—Mitoxantrone—prostate cancer	3.41e-05	0.000159	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—prostate cancer	3.41e-05	0.000158	CcSEcCtD
Metronidazole—Convulsion—Prednisone—prostate cancer	3.4e-05	0.000158	CcSEcCtD
Metronidazole—Visual impairment—Epirubicin—prostate cancer	3.39e-05	0.000158	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—prostate cancer	3.39e-05	0.000157	CcSEcCtD
Metronidazole—Hypertension—Prednisone—prostate cancer	3.39e-05	0.000157	CcSEcCtD
Metronidazole—Rash—Mitoxantrone—prostate cancer	3.38e-05	0.000157	CcSEcCtD
Metronidazole—Dermatitis—Mitoxantrone—prostate cancer	3.38e-05	0.000157	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.38e-05	0.000157	CcSEcCtD
Metronidazole—Headache—Mitoxantrone—prostate cancer	3.36e-05	0.000156	CcSEcCtD
Metronidazole—Insomnia—Docetaxel—prostate cancer	3.36e-05	0.000156	CcSEcCtD
Metronidazole—Arthralgia—Prednisone—prostate cancer	3.34e-05	0.000155	CcSEcCtD
Metronidazole—Paraesthesia—Docetaxel—prostate cancer	3.33e-05	0.000155	CcSEcCtD
Metronidazole—Erythema multiforme—Epirubicin—prostate cancer	3.33e-05	0.000155	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.32e-05	0.000154	CcSEcCtD
Metronidazole—Somnolence—Docetaxel—prostate cancer	3.3e-05	0.000153	CcSEcCtD
Metronidazole—Eye disorder—Epirubicin—prostate cancer	3.29e-05	0.000153	CcSEcCtD
Metronidazole—Hypersensitivity—Etoposide—prostate cancer	3.29e-05	0.000153	CcSEcCtD
Metronidazole—Tinnitus—Epirubicin—prostate cancer	3.28e-05	0.000153	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.27e-05	0.000152	CcSEcCtD
Metronidazole—Cardiac disorder—Epirubicin—prostate cancer	3.27e-05	0.000152	CcSEcCtD
Metronidazole—Flushing—Epirubicin—prostate cancer	3.27e-05	0.000152	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—prostate cancer	3.27e-05	0.000152	CcSEcCtD
Metronidazole—Dyspepsia—Docetaxel—prostate cancer	3.27e-05	0.000152	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—prostate cancer	3.26e-05	0.000151	CcSEcCtD
Metronidazole—Insomnia—Capecitabine—prostate cancer	3.25e-05	0.000151	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—prostate cancer	3.24e-05	0.000151	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—prostate cancer	3.23e-05	0.00015	CcSEcCtD
Metronidazole—Paraesthesia—Capecitabine—prostate cancer	3.23e-05	0.00015	CcSEcCtD
Metronidazole—Decreased appetite—Docetaxel—prostate cancer	3.23e-05	0.00015	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Docetaxel—prostate cancer	3.2e-05	0.000149	CcSEcCtD
Metronidazole—Asthenia—Etoposide—prostate cancer	3.2e-05	0.000149	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—prostate cancer	3.2e-05	0.000149	CcSEcCtD
Metronidazole—Oedema—Prednisone—prostate cancer	3.2e-05	0.000149	CcSEcCtD
Metronidazole—Anaphylactic shock—Prednisone—prostate cancer	3.2e-05	0.000149	CcSEcCtD
Metronidazole—Fatigue—Docetaxel—prostate cancer	3.2e-05	0.000149	CcSEcCtD
Metronidazole—Angiopathy—Epirubicin—prostate cancer	3.2e-05	0.000148	CcSEcCtD
Metronidazole—Nausea—Mitoxantrone—prostate cancer	3.19e-05	0.000148	CcSEcCtD
Metronidazole—Immune system disorder—Epirubicin—prostate cancer	3.18e-05	0.000148	CcSEcCtD
Metronidazole—Infection—Prednisone—prostate cancer	3.18e-05	0.000148	CcSEcCtD
Metronidazole—Mediastinal disorder—Epirubicin—prostate cancer	3.17e-05	0.000147	CcSEcCtD
Metronidazole—Constipation—Docetaxel—prostate cancer	3.17e-05	0.000147	CcSEcCtD
Metronidazole—Pain—Docetaxel—prostate cancer	3.17e-05	0.000147	CcSEcCtD
Metronidazole—Dyspepsia—Capecitabine—prostate cancer	3.16e-05	0.000147	CcSEcCtD
Metronidazole—Pruritus—Etoposide—prostate cancer	3.16e-05	0.000147	CcSEcCtD
Metronidazole—Shock—Prednisone—prostate cancer	3.15e-05	0.000146	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—prostate cancer	3.14e-05	0.000146	CcSEcCtD
Metronidazole—Nervous system disorder—Prednisone—prostate cancer	3.14e-05	0.000146	CcSEcCtD
Metronidazole—Decreased appetite—Capecitabine—prostate cancer	3.12e-05	0.000145	CcSEcCtD
Metronidazole—Skin disorder—Prednisone—prostate cancer	3.11e-05	0.000144	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Capecitabine—prostate cancer	3.1e-05	0.000144	CcSEcCtD
Metronidazole—Fatigue—Capecitabine—prostate cancer	3.1e-05	0.000144	CcSEcCtD
Metronidazole—Hyperhidrosis—Prednisone—prostate cancer	3.09e-05	0.000144	CcSEcCtD
Metronidazole—Mental disorder—Epirubicin—prostate cancer	3.09e-05	0.000143	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—prostate cancer	3.08e-05	0.000143	CcSEcCtD
Metronidazole—Constipation—Capecitabine—prostate cancer	3.07e-05	0.000143	CcSEcCtD
Metronidazole—Pain—Capecitabine—prostate cancer	3.07e-05	0.000143	CcSEcCtD
Metronidazole—Erythema—Epirubicin—prostate cancer	3.07e-05	0.000142	CcSEcCtD
Metronidazole—Feeling abnormal—Docetaxel—prostate cancer	3.06e-05	0.000142	CcSEcCtD
Metronidazole—Diarrhoea—Etoposide—prostate cancer	3.05e-05	0.000142	CcSEcCtD
Metronidazole—Anorexia—Prednisone—prostate cancer	3.05e-05	0.000142	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—prostate cancer	3.05e-05	0.000141	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—prostate cancer	3.04e-05	0.000141	CcSEcCtD
Metronidazole—Gastrointestinal pain—Docetaxel—prostate cancer	3.03e-05	0.000141	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—prostate cancer	3.02e-05	0.000141	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—prostate cancer	3.02e-05	0.000141	CcSEcCtD
Metronidazole—Flatulence—Epirubicin—prostate cancer	3.02e-05	0.00014	CcSEcCtD
Metronidazole—Dysgeusia—Epirubicin—prostate cancer	3e-05	0.000139	CcSEcCtD
Metronidazole—Back pain—Epirubicin—prostate cancer	2.97e-05	0.000138	CcSEcCtD
Metronidazole—Feeling abnormal—Capecitabine—prostate cancer	2.96e-05	0.000138	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—prostate cancer	2.96e-05	0.000137	CcSEcCtD
Metronidazole—Dizziness—Etoposide—prostate cancer	2.95e-05	0.000137	CcSEcCtD
Metronidazole—Muscle spasms—Epirubicin—prostate cancer	2.95e-05	0.000137	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—prostate cancer	2.94e-05	0.000137	CcSEcCtD
Metronidazole—Gastrointestinal pain—Capecitabine—prostate cancer	2.94e-05	0.000136	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—prostate cancer	2.94e-05	0.000136	CcSEcCtD
Metronidazole—Abdominal pain—Docetaxel—prostate cancer	2.93e-05	0.000136	CcSEcCtD
Metronidazole—Body temperature increased—Docetaxel—prostate cancer	2.93e-05	0.000136	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Prednisone—prostate cancer	2.92e-05	0.000135	CcSEcCtD
Metronidazole—Insomnia—Prednisone—prostate cancer	2.89e-05	0.000134	CcSEcCtD
Metronidazole—Vision blurred—Epirubicin—prostate cancer	2.89e-05	0.000134	CcSEcCtD
Metronidazole—Paraesthesia—Prednisone—prostate cancer	2.87e-05	0.000133	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—prostate cancer	2.86e-05	0.000133	CcSEcCtD
Metronidazole—Urticaria—Capecitabine—prostate cancer	2.85e-05	0.000133	CcSEcCtD
Metronidazole—Abdominal pain—Capecitabine—prostate cancer	2.84e-05	0.000132	CcSEcCtD
Metronidazole—Body temperature increased—Capecitabine—prostate cancer	2.84e-05	0.000132	CcSEcCtD
Metronidazole—Vomiting—Etoposide—prostate cancer	2.84e-05	0.000132	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—prostate cancer	2.84e-05	0.000132	CcSEcCtD
Metronidazole—Dyspepsia—Prednisone—prostate cancer	2.82e-05	0.000131	CcSEcCtD
Metronidazole—Rash—Etoposide—prostate cancer	2.82e-05	0.000131	CcSEcCtD
Metronidazole—Dermatitis—Etoposide—prostate cancer	2.81e-05	0.000131	CcSEcCtD
Metronidazole—Headache—Etoposide—prostate cancer	2.8e-05	0.00013	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—prostate cancer	2.8e-05	0.00013	CcSEcCtD
Metronidazole—Decreased appetite—Prednisone—prostate cancer	2.78e-05	0.000129	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—prostate cancer	2.78e-05	0.000129	CcSEcCtD
Metronidazole—Malaise—Epirubicin—prostate cancer	2.77e-05	0.000128	CcSEcCtD
Metronidazole—Fatigue—Prednisone—prostate cancer	2.76e-05	0.000128	CcSEcCtD
Metronidazole—Vertigo—Epirubicin—prostate cancer	2.76e-05	0.000128	CcSEcCtD
Metronidazole—Syncope—Epirubicin—prostate cancer	2.75e-05	0.000128	CcSEcCtD
Metronidazole—Leukopenia—Epirubicin—prostate cancer	2.74e-05	0.000128	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—prostate cancer	2.74e-05	0.000127	CcSEcCtD
Metronidazole—Constipation—Prednisone—prostate cancer	2.74e-05	0.000127	CcSEcCtD
Metronidazole—Hypersensitivity—Docetaxel—prostate cancer	2.73e-05	0.000127	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—prostate cancer	2.73e-05	0.000127	CcSEcCtD
Metronidazole—Palpitations—Epirubicin—prostate cancer	2.71e-05	0.000126	CcSEcCtD
Metronidazole—Loss of consciousness—Epirubicin—prostate cancer	2.7e-05	0.000125	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—prostate cancer	2.67e-05	0.000124	CcSEcCtD
Metronidazole—Asthenia—Docetaxel—prostate cancer	2.66e-05	0.000124	CcSEcCtD
Metronidazole—Convulsion—Epirubicin—prostate cancer	2.66e-05	0.000123	CcSEcCtD
Metronidazole—Nausea—Etoposide—prostate cancer	2.65e-05	0.000123	CcSEcCtD
Metronidazole—Hypertension—Epirubicin—prostate cancer	2.65e-05	0.000123	CcSEcCtD
Metronidazole—Hypersensitivity—Capecitabine—prostate cancer	2.65e-05	0.000123	CcSEcCtD
Metronidazole—Feeling abnormal—Prednisone—prostate cancer	2.64e-05	0.000122	CcSEcCtD
Metronidazole—Pruritus—Docetaxel—prostate cancer	2.63e-05	0.000122	CcSEcCtD
Metronidazole—Gastrointestinal pain—Prednisone—prostate cancer	2.62e-05	0.000122	CcSEcCtD
Metronidazole—Chest pain—Epirubicin—prostate cancer	2.61e-05	0.000121	CcSEcCtD
Metronidazole—Arthralgia—Epirubicin—prostate cancer	2.61e-05	0.000121	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.59e-05	0.00012	CcSEcCtD
Metronidazole—Asthenia—Capecitabine—prostate cancer	2.58e-05	0.00012	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—prostate cancer	2.56e-05	0.000119	CcSEcCtD
Metronidazole—Dry mouth—Epirubicin—prostate cancer	2.55e-05	0.000119	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—prostate cancer	2.55e-05	0.000118	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—prostate cancer	2.54e-05	0.000118	CcSEcCtD
Metronidazole—Urticaria—Prednisone—prostate cancer	2.54e-05	0.000118	CcSEcCtD
Metronidazole—Pruritus—Capecitabine—prostate cancer	2.54e-05	0.000118	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—prostate cancer	2.54e-05	0.000118	CcSEcCtD
Metronidazole—Diarrhoea—Docetaxel—prostate cancer	2.54e-05	0.000118	CcSEcCtD
Metronidazole—Abdominal pain—Prednisone—prostate cancer	2.53e-05	0.000118	CcSEcCtD
Metronidazole—Body temperature increased—Prednisone—prostate cancer	2.53e-05	0.000118	CcSEcCtD
Metronidazole—Confusional state—Epirubicin—prostate cancer	2.52e-05	0.000117	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—prostate cancer	2.51e-05	0.000116	CcSEcCtD
Metronidazole—Oedema—Epirubicin—prostate cancer	2.5e-05	0.000116	CcSEcCtD
Metronidazole—Anaphylactic shock—Epirubicin—prostate cancer	2.5e-05	0.000116	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—prostate cancer	2.49e-05	0.000116	CcSEcCtD
Metronidazole—Infection—Epirubicin—prostate cancer	2.49e-05	0.000115	CcSEcCtD
Metronidazole—Shock—Epirubicin—prostate cancer	2.46e-05	0.000114	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—prostate cancer	2.46e-05	0.000114	CcSEcCtD
Metronidazole—Diarrhoea—Capecitabine—prostate cancer	2.46e-05	0.000114	CcSEcCtD
Metronidazole—Nervous system disorder—Epirubicin—prostate cancer	2.45e-05	0.000114	CcSEcCtD
Metronidazole—Dizziness—Docetaxel—prostate cancer	2.45e-05	0.000114	CcSEcCtD
Metronidazole—Thrombocytopenia—Epirubicin—prostate cancer	2.45e-05	0.000114	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—prostate cancer	2.45e-05	0.000114	CcSEcCtD
Metronidazole—Skin disorder—Epirubicin—prostate cancer	2.43e-05	0.000113	CcSEcCtD
Metronidazole—Hyperhidrosis—Epirubicin—prostate cancer	2.42e-05	0.000112	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—prostate cancer	2.42e-05	0.000112	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—prostate cancer	2.42e-05	0.000112	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.4e-05	0.000111	CcSEcCtD
Metronidazole—Anorexia—Epirubicin—prostate cancer	2.39e-05	0.000111	CcSEcCtD
Metronidazole—Dizziness—Capecitabine—prostate cancer	2.38e-05	0.00011	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—prostate cancer	2.36e-05	0.00011	CcSEcCtD
Metronidazole—Vomiting—Docetaxel—prostate cancer	2.36e-05	0.00011	CcSEcCtD
Metronidazole—Hypersensitivity—Prednisone—prostate cancer	2.36e-05	0.00011	CcSEcCtD
Metronidazole—Rash—Docetaxel—prostate cancer	2.34e-05	0.000109	CcSEcCtD
Metronidazole—Dermatitis—Docetaxel—prostate cancer	2.34e-05	0.000109	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—prostate cancer	2.33e-05	0.000108	CcSEcCtD
Metronidazole—Headache—Docetaxel—prostate cancer	2.32e-05	0.000108	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—prostate cancer	2.32e-05	0.000108	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—prostate cancer	2.32e-05	0.000108	CcSEcCtD
Metronidazole—Infection—Doxorubicin—prostate cancer	2.3e-05	0.000107	CcSEcCtD
Metronidazole—Asthenia—Prednisone—prostate cancer	2.3e-05	0.000107	CcSEcCtD
Metronidazole—Vomiting—Capecitabine—prostate cancer	2.28e-05	0.000106	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.28e-05	0.000106	CcSEcCtD
Metronidazole—Shock—Doxorubicin—prostate cancer	2.28e-05	0.000106	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—prostate cancer	2.27e-05	0.000105	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—prostate cancer	2.27e-05	0.000105	CcSEcCtD
Metronidazole—Rash—Capecitabine—prostate cancer	2.27e-05	0.000105	CcSEcCtD
Metronidazole—Pruritus—Prednisone—prostate cancer	2.26e-05	0.000105	CcSEcCtD
Metronidazole—Insomnia—Epirubicin—prostate cancer	2.26e-05	0.000105	CcSEcCtD
Metronidazole—Dermatitis—Capecitabine—prostate cancer	2.26e-05	0.000105	CcSEcCtD
Metronidazole—Headache—Capecitabine—prostate cancer	2.25e-05	0.000105	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—prostate cancer	2.25e-05	0.000104	CcSEcCtD
Metronidazole—Paraesthesia—Epirubicin—prostate cancer	2.25e-05	0.000104	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—prostate cancer	2.24e-05	0.000104	CcSEcCtD
Metronidazole—Somnolence—Epirubicin—prostate cancer	2.22e-05	0.000103	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—prostate cancer	2.21e-05	0.000103	CcSEcCtD
Metronidazole—Nausea—Docetaxel—prostate cancer	2.2e-05	0.000102	CcSEcCtD
Metronidazole—Dyspepsia—Epirubicin—prostate cancer	2.2e-05	0.000102	CcSEcCtD
Metronidazole—Diarrhoea—Prednisone—prostate cancer	2.19e-05	0.000102	CcSEcCtD
Metronidazole—Decreased appetite—Epirubicin—prostate cancer	2.18e-05	0.000101	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Epirubicin—prostate cancer	2.16e-05	0.0001	CcSEcCtD
Metronidazole—Fatigue—Epirubicin—prostate cancer	2.16e-05	0.0001	CcSEcCtD
Metronidazole—Pain—Epirubicin—prostate cancer	2.14e-05	9.94e-05	CcSEcCtD
Metronidazole—Constipation—Epirubicin—prostate cancer	2.14e-05	9.94e-05	CcSEcCtD
Metronidazole—Nausea—Capecitabine—prostate cancer	2.13e-05	9.91e-05	CcSEcCtD
Metronidazole—Dizziness—Prednisone—prostate cancer	2.12e-05	9.83e-05	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.11e-05	9.8e-05	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—prostate cancer	2.09e-05	9.73e-05	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—prostate cancer	2.08e-05	9.66e-05	CcSEcCtD
Metronidazole—Feeling abnormal—Epirubicin—prostate cancer	2.06e-05	9.58e-05	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—prostate cancer	2.06e-05	9.56e-05	CcSEcCtD
Metronidazole—Gastrointestinal pain—Epirubicin—prostate cancer	2.05e-05	9.51e-05	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—prostate cancer	2.04e-05	9.47e-05	CcSEcCtD
Metronidazole—Vomiting—Prednisone—prostate cancer	2.03e-05	9.45e-05	CcSEcCtD
Metronidazole—Rash—Prednisone—prostate cancer	2.02e-05	9.37e-05	CcSEcCtD
Metronidazole—Dermatitis—Prednisone—prostate cancer	2.02e-05	9.36e-05	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—prostate cancer	2.01e-05	9.35e-05	CcSEcCtD
Metronidazole—Headache—Prednisone—prostate cancer	2e-05	9.31e-05	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—prostate cancer	2e-05	9.29e-05	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—prostate cancer	2e-05	9.27e-05	CcSEcCtD
Metronidazole—Urticaria—Epirubicin—prostate cancer	1.99e-05	9.24e-05	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—prostate cancer	1.98e-05	9.2e-05	CcSEcCtD
Metronidazole—Pain—Doxorubicin—prostate cancer	1.98e-05	9.2e-05	CcSEcCtD
Metronidazole—Body temperature increased—Epirubicin—prostate cancer	1.98e-05	9.19e-05	CcSEcCtD
Metronidazole—Abdominal pain—Epirubicin—prostate cancer	1.98e-05	9.19e-05	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—prostate cancer	1.91e-05	8.86e-05	CcSEcCtD
Metronidazole—Nausea—Prednisone—prostate cancer	1.9e-05	8.83e-05	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—prostate cancer	1.89e-05	8.8e-05	CcSEcCtD
Metronidazole—Hypersensitivity—Epirubicin—prostate cancer	1.84e-05	8.56e-05	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—prostate cancer	1.84e-05	8.55e-05	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—prostate cancer	1.83e-05	8.5e-05	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—prostate cancer	1.83e-05	8.5e-05	CcSEcCtD
Metronidazole—Asthenia—Epirubicin—prostate cancer	1.8e-05	8.34e-05	CcSEcCtD
Metronidazole—Pruritus—Epirubicin—prostate cancer	1.77e-05	8.22e-05	CcSEcCtD
Metronidazole—Diarrhoea—Epirubicin—prostate cancer	1.71e-05	7.95e-05	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—prostate cancer	1.71e-05	7.92e-05	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—prostate cancer	1.66e-05	7.72e-05	CcSEcCtD
Metronidazole—Dizziness—Epirubicin—prostate cancer	1.65e-05	7.69e-05	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—prostate cancer	1.64e-05	7.61e-05	CcSEcCtD
Metronidazole—Vomiting—Epirubicin—prostate cancer	1.59e-05	7.39e-05	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—prostate cancer	1.58e-05	7.36e-05	CcSEcCtD
Metronidazole—Rash—Epirubicin—prostate cancer	1.58e-05	7.33e-05	CcSEcCtD
Metronidazole—Dermatitis—Epirubicin—prostate cancer	1.58e-05	7.32e-05	CcSEcCtD
Metronidazole—Headache—Epirubicin—prostate cancer	1.57e-05	7.28e-05	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—prostate cancer	1.53e-05	7.11e-05	CcSEcCtD
Metronidazole—Nausea—Epirubicin—prostate cancer	1.49e-05	6.91e-05	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—prostate cancer	1.47e-05	6.84e-05	CcSEcCtD
Metronidazole—Rash—Doxorubicin—prostate cancer	1.46e-05	6.78e-05	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—prostate cancer	1.46e-05	6.78e-05	CcSEcCtD
Metronidazole—Headache—Doxorubicin—prostate cancer	1.45e-05	6.74e-05	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—prostate cancer	1.38e-05	6.39e-05	CcSEcCtD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.34e-05	0.00018	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.34e-05	0.000179	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.32e-05	0.000177	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTA4—prostate cancer	1.32e-05	0.000177	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—TBXAS1—prostate cancer	1.32e-05	0.000177	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ACSL4—prostate cancer	1.32e-05	0.000177	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HSD17B3—prostate cancer	1.32e-05	0.000177	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.31e-05	0.000175	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.29e-05	0.000173	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTA2—prostate cancer	1.29e-05	0.000173	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCG5—prostate cancer	1.27e-05	0.000171	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SULT1A1—prostate cancer	1.27e-05	0.000171	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AOX1—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NAGLU—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTM3—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—RFK—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PGAM2—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ARG2—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—UMPS—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PHGDH—prostate cancer	1.27e-05	0.00017	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.26e-05	0.000169	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTA1—prostate cancer	1.24e-05	0.000167	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LDHB—prostate cancer	1.24e-05	0.000166	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NAT2—prostate cancer	1.23e-05	0.000165	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HSD3B2—prostate cancer	1.23e-05	0.000165	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTO1—prostate cancer	1.23e-05	0.000165	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP3A5—prostate cancer	1.22e-05	0.000163	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AMACR—prostate cancer	1.2e-05	0.000161	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.2e-05	0.000161	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—DEGS1—prostate cancer	1.2e-05	0.000161	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NAT1—prostate cancer	1.2e-05	0.000161	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.2e-05	0.000161	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.18e-05	0.000158	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PLCB2—prostate cancer	1.18e-05	0.000158	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2C18—prostate cancer	1.18e-05	0.000158	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LRP2—prostate cancer	1.18e-05	0.000158	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PDHA1—prostate cancer	1.18e-05	0.000158	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTA3—prostate cancer	1.18e-05	0.000158	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—TCN2—prostate cancer	1.18e-05	0.000158	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—UCP3—prostate cancer	1.18e-05	0.000158	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—P4HB—prostate cancer	1.16e-05	0.000155	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.15e-05	0.000154	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SLC22A1—prostate cancer	1.12e-05	0.000151	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SLC22A3—prostate cancer	1.12e-05	0.00015	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HSD3B1—prostate cancer	1.12e-05	0.00015	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.11e-05	0.000149	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SULT2A1—prostate cancer	1.1e-05	0.000147	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.09e-05	0.000146	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—MED12—prostate cancer	1.08e-05	0.000144	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTA4—prostate cancer	1.08e-05	0.000144	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—TBXAS1—prostate cancer	1.08e-05	0.000144	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GNG5—prostate cancer	1.07e-05	0.000143	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.05e-05	0.000141	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTA2—prostate cancer	1.05e-05	0.000141	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SULT1A1—prostate cancer	1.04e-05	0.000139	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCG5—prostate cancer	1.04e-05	0.000139	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NCOA3—prostate cancer	1.03e-05	0.000138	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.02e-05	0.000137	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HPGD—prostate cancer	1.02e-05	0.000137	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.01e-05	0.000136	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTA1—prostate cancer	1.01e-05	0.000136	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NAT2—prostate cancer	1e-05	0.000134	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HSD3B2—prostate cancer	1e-05	0.000134	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTO1—prostate cancer	1e-05	0.000134	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HPGDS—prostate cancer	9.83e-06	0.000132	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2C19—prostate cancer	9.77e-06	0.000131	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TNFRSF21—prostate cancer	9.63e-06	0.000129	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.63e-06	0.000129	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PLCB2—prostate cancer	9.6e-06	0.000129	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2C18—prostate cancer	9.6e-06	0.000129	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LRP2—prostate cancer	9.6e-06	0.000129	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTT1—prostate cancer	9.54e-06	0.000128	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ACHE—prostate cancer	9.54e-06	0.000128	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2A6—prostate cancer	9.43e-06	0.000126	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—P4HB—prostate cancer	9.41e-06	0.000126	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	9.39e-06	0.000126	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP7B1—prostate cancer	9.37e-06	0.000125	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—MTAP—prostate cancer	9.37e-06	0.000125	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKR1C3—prostate cancer	9.17e-06	0.000123	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SLC22A1—prostate cancer	9.16e-06	0.000123	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SULT1E1—prostate cancer	9.13e-06	0.000122	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SRD5A1—prostate cancer	9.13e-06	0.000122	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PRKACB—prostate cancer	9.12e-06	0.000122	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	9.05e-06	0.000121	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP17A1—prostate cancer	9.03e-06	0.000121	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SULT2A1—prostate cancer	8.92e-06	0.000119	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	8.9e-06	0.000119	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—MED12—prostate cancer	8.78e-06	0.000118	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ACSL4—prostate cancer	8.71e-06	0.000117	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HSD17B3—prostate cancer	8.71e-06	0.000117	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GNG5—prostate cancer	8.71e-06	0.000117	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NCOA2—prostate cancer	8.6e-06	0.000115	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NCOA3—prostate cancer	8.39e-06	0.000112	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PHGDH—prostate cancer	8.35e-06	0.000112	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—UMPS—prostate cancer	8.35e-06	0.000112	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ARG2—prostate cancer	8.35e-06	0.000112	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8.24e-06	0.00011	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SLC5A5—prostate cancer	8.21e-06	0.00011	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LDHB—prostate cancer	8.19e-06	0.00011	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP3A5—prostate cancer	8.04e-06	0.000108	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2E1—prostate cancer	8.02e-06	0.000107	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HPGDS—prostate cancer	8e-06	0.000107	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2C19—prostate cancer	7.95e-06	0.000107	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NQO1—prostate cancer	7.93e-06	0.000106	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—TH—prostate cancer	7.81e-06	0.000105	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PDHA1—prostate cancer	7.76e-06	0.000104	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTA3—prostate cancer	7.76e-06	0.000104	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—UCP3—prostate cancer	7.76e-06	0.000104	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TCN2—prostate cancer	7.76e-06	0.000104	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ACHE—prostate cancer	7.76e-06	0.000104	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTT1—prostate cancer	7.76e-06	0.000104	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.76e-06	0.000104	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP3A4—prostate cancer	7.73e-06	0.000104	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.69e-06	0.000103	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2A6—prostate cancer	7.67e-06	0.000103	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.64e-06	0.000102	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP1B1—prostate cancer	7.6e-06	0.000102	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKR1C3—prostate cancer	7.46e-06	0.0001	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PRKACB—prostate cancer	7.42e-06	9.94e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HSD3B1—prostate cancer	7.41e-06	9.92e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SLC22A3—prostate cancer	7.41e-06	9.92e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GGT1—prostate cancer	7.36e-06	9.86e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP17A1—prostate cancer	7.35e-06	9.84e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NCOA1—prostate cancer	7.25e-06	9.71e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.25e-06	9.71e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP19A1—prostate cancer	7.14e-06	9.57e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TBXAS1—prostate cancer	7.1e-06	9.51e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTA4—prostate cancer	7.1e-06	9.51e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NCOA2—prostate cancer	7e-06	9.38e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTA2—prostate cancer	6.92e-06	9.27e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—RXRA—prostate cancer	6.89e-06	9.23e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SULT1A1—prostate cancer	6.84e-06	9.16e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCG5—prostate cancer	6.84e-06	9.16e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.71e-06	8.98e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SLC5A5—prostate cancer	6.68e-06	8.95e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTA1—prostate cancer	6.68e-06	8.94e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—COMT—prostate cancer	6.64e-06	8.9e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTP1—prostate cancer	6.61e-06	8.85e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTO1—prostate cancer	6.6e-06	8.84e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NAT2—prostate cancer	6.6e-06	8.84e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HSD3B2—prostate cancer	6.6e-06	8.84e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2E1—prostate cancer	6.52e-06	8.74e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ITPR1—prostate cancer	6.5e-06	8.71e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NQO1—prostate cancer	6.45e-06	8.64e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.4e-06	8.57e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—TH—prostate cancer	6.36e-06	8.51e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2C18—prostate cancer	6.33e-06	8.48e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PLCB2—prostate cancer	6.33e-06	8.48e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LRP2—prostate cancer	6.33e-06	8.48e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.32e-06	8.46e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP3A4—prostate cancer	6.29e-06	8.43e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.26e-06	8.38e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—P4HB—prostate cancer	6.21e-06	8.31e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP1B1—prostate cancer	6.18e-06	8.28e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—TYMS—prostate cancer	6.15e-06	8.23e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTM1—prostate cancer	6.07e-06	8.14e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SLC22A1—prostate cancer	6.04e-06	8.09e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GGT1—prostate cancer	5.99e-06	8.02e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LPL—prostate cancer	5.96e-06	7.99e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NCOA1—prostate cancer	5.9e-06	7.9e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.88e-06	7.88e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP19A1—prostate cancer	5.81e-06	7.79e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—MED12—prostate cancer	5.79e-06	7.75e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP1A1—prostate cancer	5.76e-06	7.71e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GNG5—prostate cancer	5.74e-06	7.69e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ERCC2—prostate cancer	5.71e-06	7.65e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—RXRA—prostate cancer	5.61e-06	7.52e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NCOA3—prostate cancer	5.53e-06	7.41e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.46e-06	7.31e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—COMT—prostate cancer	5.41e-06	7.24e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTP1—prostate cancer	5.38e-06	7.21e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—MTHFR—prostate cancer	5.37e-06	7.19e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ITPR1—prostate cancer	5.29e-06	7.09e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HPGDS—prostate cancer	5.28e-06	7.07e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PPARA—prostate cancer	5.27e-06	7.05e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.24e-06	7.02e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.2e-06	6.97e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ACHE—prostate cancer	5.12e-06	6.86e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTT1—prostate cancer	5.12e-06	6.86e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2A6—prostate cancer	5.06e-06	6.78e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—TYMS—prostate cancer	5e-06	6.7e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CAV1—prostate cancer	4.95e-06	6.63e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTM1—prostate cancer	4.94e-06	6.62e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.92e-06	6.59e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PRKACB—prostate cancer	4.9e-06	6.56e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LPL—prostate cancer	4.85e-06	6.5e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.85e-06	6.49e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.73e-06	6.34e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP1A1—prostate cancer	4.69e-06	6.28e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ERCC2—prostate cancer	4.65e-06	6.23e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NCOA2—prostate cancer	4.62e-06	6.18e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CG—prostate cancer	4.51e-06	6.04e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.4e-06	5.9e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—MTHFR—prostate cancer	4.37e-06	5.85e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.3e-06	5.76e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PPARA—prostate cancer	4.29e-06	5.74e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—INS—prostate cancer	4.27e-06	5.72e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NQO1—prostate cancer	4.25e-06	5.7e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TH—prostate cancer	4.19e-06	5.62e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CREBBP—prostate cancer	4.18e-06	5.6e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.08e-06	5.46e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CAV1—prostate cancer	4.03e-06	5.4e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CD—prostate cancer	3.97e-06	5.31e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GGT1—prostate cancer	3.95e-06	5.29e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NCOA1—prostate cancer	3.89e-06	5.21e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.85e-06	5.16e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.83e-06	5.14e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NOS3—prostate cancer	3.74e-06	5.01e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—RXRA—prostate cancer	3.7e-06	4.96e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.67e-06	4.92e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—COMT—prostate cancer	3.56e-06	4.77e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTP1—prostate cancer	3.55e-06	4.75e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ITPR1—prostate cancer	3.49e-06	4.68e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—INS—prostate cancer	3.47e-06	4.65e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CB—prostate cancer	3.46e-06	4.63e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PTGS2—prostate cancer	3.42e-06	4.59e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CREBBP—prostate cancer	3.4e-06	4.56e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TYMS—prostate cancer	3.3e-06	4.42e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTM1—prostate cancer	3.26e-06	4.37e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CD—prostate cancer	3.23e-06	4.32e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LPL—prostate cancer	3.2e-06	4.29e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.09e-06	4.14e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ERCC2—prostate cancer	3.07e-06	4.11e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NOS3—prostate cancer	3.05e-06	4.08e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PTEN—prostate cancer	2.99e-06	4e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—MTHFR—prostate cancer	2.88e-06	3.86e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—EP300—prostate cancer	2.85e-06	3.81e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PPARA—prostate cancer	2.83e-06	3.79e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.81e-06	3.77e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PTGS2—prostate cancer	2.79e-06	3.73e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CAV1—prostate cancer	2.66e-06	3.56e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PTEN—prostate cancer	2.43e-06	3.26e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.42e-06	3.24e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—EP300—prostate cancer	2.32e-06	3.1e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—INS—prostate cancer	2.29e-06	3.07e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CREBBP—prostate cancer	2.24e-06	3.01e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.13e-06	2.85e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CA—prostate cancer	2.11e-06	2.82e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NOS3—prostate cancer	2.01e-06	2.69e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.86e-06	2.48e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PTGS2—prostate cancer	1.84e-06	2.46e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKT1—prostate cancer	1.72e-06	2.31e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.71e-06	2.3e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PTEN—prostate cancer	1.6e-06	2.15e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—EP300—prostate cancer	1.53e-06	2.05e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKT1—prostate cancer	1.4e-06	1.88e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.13e-06	1.51e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKT1—prostate cancer	9.24e-07	1.24e-05	CbGpPWpGaD
